Motor neurone disease is a rapidly progressing and complex disease, yet too many Australians living with MND face delays, inequities and barriers to accessing essential care and support.

Where someone lives, their age and the government system they rely on can all affect the level of support they receive. For people living with MND, these differences can have a profound impact on their quality of life.

MND Australia works with our State MND Associations, people with lived experience, researchers and health professionals to advocate for changes to government policy, funding and services.

Our five national advocacy priorities focus on improving access to specialist care, ensuring timely and equitable support, and ensuring that when treatments become available, they are accessible to all.

Advocacy priorities:

  1. Increase access to specialist care and research

  2. Fast-track access to level 8 Support at Home aged care packages

  3. Fund supports commensurate with need

  4. Support access to residential aged care through targeted financial loading and workforce development.

  5. Protect future generations through genetic testing and counselling

1. Increase access to specialist care and research

Geographic location currently determines whether someone can access specialist MND clinics, research opportunities, and experienced allied health care professionals.

MND Australia is seeking $30 million over three years to support clinic coordination, expand research opportunities to all clinics, improve outreach to regional and remote areas, and strengthen the role of MND State Associations in delivering coordinated care at home.

Cost: $30 million over 3 years


2. Fast-track access to level 8 Support at Home aged care packages

In response to years of sustained advocacy from the MND community, on 3 June 2026, the Department of Health, Disability and Aging announced that people diagnosed with motor neurone disease would receive fast-track access to aged care Support at Home packages. Fast-track access means that people living with MND should receive approval for a Support at Home package within 30 days of application.

While MND Australia welcomes this change, people with MND are still not being approved at a package level that means they can live safely at home.

MND Australia is therefore calling for immediate access to the highest level funding support, level 8 Support at Home packages for people living with MND.


3. Fund supports commensurate with need

People diagnosed with MND aged 65 and over receive significantly less funding and support through Aged Care than those currently supported by the NDIS, despite having the same needs.

MND Australia is requesting investment of $287 million per year to address this age-based inequity and ensure timely, adequate supports for all people living with MND.

Cost: $287 million a year


4. Support access to residential aged care through targeted financial loading and workforce development

People living with MND are ‘clinically declined’ from residential aged care, due to the complexity of their care needs. Financial loading to cover the cost of providing complex clinical care, combined with an investment in upskilling the aged care workforce, would reduce unnecessary hospital stays and provide people living with MND a safe place to stay when home is no longer an option.


5. Protect future generations through genetic testing and counselling

Up to 15 percent of MND cases have a known genetic basis. MND Australia is calling for Medicare-rebated genetic counselling and no-cost access to IVF and pre-implantation genetic testing for families who choose this option, to protect future generations.